PACB (STOCKS)
Pacific Biosciences of California, Inc.
$1.439500
+0.099500 (+7.43%)
Prev close: $1.340000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Christian O. Henry
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $440.92M
- Employees
- 575
- P/E (TTM)
- -0.79
- P/B (TTM)
- 75.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
6
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.12 | $-0.15 | +0.0305 | +20.27% |
|
Sep 2025 (Q3)
|
$-0.13 | $-0.16 | +0.0250 | +16.13% |
|
Jun 2025 (Q2)
|
$-0.14 | $-0.17 | +0.0334 | +19.26% |
|
Mar 2025 (Q1)
|
$-1.44 | $-0.19 | -1.2472 | -646.89% |
Financial Statements
| Revenues | $160.01M |
| Benefits Costs and Expenses | $706.06M |
| Cost Of Revenue | $114.23M |
| Costs And Expenses | $706.06M |
| Gross Profit | $45.78M |
| Operating Expenses | $599.64M |
| Selling, General, and Administrative Expenses | $141.49M |
| Research and Development | $97.31M |
| Other Operating Expenses | $360.84M |
| Operating Income/Loss | -$553.86M |
| Income/Loss From Continuing Operations After Tax | -$546.38M |
| Income/Loss From Continuing Operations Before Tax | -$546.06M |
| Income Tax Expense/Benefit | $318.00K |
| Income Tax Expense/Benefit, Current | $864.00K |
| Income Tax Expense/Benefit, Deferred | -$546.00K |
| Net Income/Loss | -$546.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$546.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$546.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.82 |
| Diluted Earnings Per Share | -$1.82 |
| Basic Average Shares | 299,959,000 |
| Diluted Average Shares | 299,959,000 |
| Assets | $784.08M |
| Current Assets | $375.05M |
| Inventory | $49.29M |
| Other Current Assets | $325.77M |
| Noncurrent Assets | $409.03M |
| Fixed Assets | $24.15M |
| Intangible Assets | $15.12M |
| Other Non-current Assets | $369.76M |
| Liabilities | $778.73M |
| Current Liabilities | $72.83M |
| Accounts Payable | $20.77M |
| Wages | $18.25M |
| Other Current Liabilities | $33.81M |
| Noncurrent Liabilities | $705.90M |
| Equity | $5.35M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.35M |
| Liabilities And Equity | $784.08M |
| Net Cash Flow From Operating Activities | -$111.21M |
| Net Cash Flow From Operating Activities, Continuing | -$111.21M |
| Net Cash Flow From Investing Activities | $115.45M |
| Net Cash Flow From Investing Activities, Continuing | $115.45M |
| Net Cash Flow From Financing Activities | $3.43M |
| Net Cash Flow From Financing Activities, Continuing | $3.43M |
| Net Cash Flow | $7.67M |
| Net Cash Flow, Continuing | $7.67M |
| Comprehensive Income/Loss | -$546.34M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$546.34M |
| Other Comprehensive Income/Loss | -$546.34M |
| Other Comprehensive Income/Loss Attributable To Parent | $35.00K |